"Canada cannot be the drugstore for the United States of America," protests Canadian Health Minister Ujjal Dosanjh. Mr. Dosanjh wants to pass legislation stemming the flow of prescription drugs from his country to ours.
But the Canadian government faces an uphill battle. Today's consumers shop for health care, like everything else, on the global market. It pays to look for drug bargains, since life-saving medication often comes at a steep price.
Companies like Merck and Pfizer spend more than $800 million to develop each new drug. Yet pills are relatively cheap in Canada because the government's universal health system refuses to pay free-market prices. To buy drugs locally, Americans must pay the full price, and then some, to make up for Canada's bullying behavior toward drug companies.
It's time to tell Mr. Dosanjh: The United States will subsidize Canadian drugs no longer.